Cannabis Watch: RIV Capital sees ‘operational challenges,’ opportunities in uncertain New York cannabis market
RIV Capital, backed by Scotts Miracle-Gro, sees opportunities despite uncertainty in the New York regulatory market and books $139 million impairment on acquisition of Etain